Clinical trial
Safety and Efficacy of Prophylactic Resorbable Biosynthetic Mesh Following Midline Laparotomy in Clean/Contaminated Field: Protocol for a Multicenter Randomized Double Blind Prospected Trial.
NCT04471311 is registered in ClinicalTrials.gov with Azienda Sanitaria Locale Napoli 2 Nord as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Prophylactic Resorbable Biosynthetic Mesh Following Midline Laparotomy in Clean/Contaminated Field: Protocol for a Multicenter Randomized Double Blind Prospected Trial.
- Lead sponsor
- Azienda Sanitaria Locale Napoli 2 Nord
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2024
- Completion date
- June 30, 2024
- Enrollment
- 151 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
incisional hernia after midline laparotomy